Rudolf Stadler - Concepedia

Author

Rudolf Stadler

Also Known As

, Deutsche Dermatologische Gesellschaft e.V.Vereinigung Deutschsprachiger Dermatologen e.V., R STADLER, R Stadler, R. STADLER, R. Stadler, Rudolf Stadler, Stadler R.

420

Publications

10.7K

Citations

H-Index

114

Concepts

All Affiliations

Johannes Wesling Klinikum Minden Freie Universität Berlin University of Lübeck University Hospital Schleswig-Holstein Heidelberg University

About

Rudolf Stadler is an author at Johannes Wesling Klinikum Minden specializing in medicine, dermatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	45	4.3K
2	Health Sciences	4	4	738
3	Public Health	2	2	290
4	Engineering	1	1	17
5	Anatomy	1	1	16

Rudolf Stadler

Publications

7.6K

Citations

H-Index

Page 1

	Year	Citations
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, The Lancet Oncology Surgical OncologyMedicineSurgical PathologyMelanomaSurgery	2016	684
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial H. Miles Prince, Youn H. Kim, Reinhard Dummer, The Lancet Hematological MalignancyLymphoid NeoplasiaMedicineClinical TrialsPathology	2017	569
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer, Journal of Clinical Oncology	2015	407
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement Nicolas Hunzelmann, E. Genth, Thomas Krieg, Lara D. Veeken	2008	285
Epidemiological features of Adamantiades-BehÇet's disease in Germany and in Europe Christos C. Zouboulis, Ina Kötter, D Djawari, Yonsei Medical Journal ImmunodeficienciesDiagnosisPathologyClinical EpidemiologyEpidemiological Features	1997	268
A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus Stefan Beissert, Thomas Werfel, Uta Frieling, Archives of Dermatology	2006	255
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial Lisa Zimmer, Elisabeth Livingstone, Jessica C. Hassel, The Lancet Surgical OncologyOncologyMelanomaImmunologyClinical Trials	2020	238
Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, Journal of Clinical Oncology	2019	236
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients Claus Garbe, Petra Büttner, J. Bertz, Cancer	1995	226
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients Julia Scarisbrick, Pietro Quaglino, H. Miles Prince, British Journal of Dermatology	2018	216

Page 1